SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001548123-12-000076
Filing Date
2012-05-15
Accepted
2012-05-15 13:02:47
Documents
10
Period of Report
2012-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ON FORM 10Q FOR THE QUARTER ENDED MARCH 31, 2012 sanguineform10qmarch12revise.htm 10-Q 194795
2 302 CERTIFICATION OF CEO ex311.htm EX-31 7307
3 302 CERTIFICATION OF CFO ex312.htm EX-31 7301
4 906 CERTIFICATION ex32.htm EX-32 4264
  Complete submission text file 0001548123-12-000076.txt   1353211

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT sgnc-20120331.xml EX-101.INS 138133
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sgnc-20120331_pre.xml EX-101.PRE 65733
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sgnc-20120331_lab.xml EX-101.LAB 86928
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT sgnc-20120331_def.xml EX-101.DEF 51933
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT sgnc-20120331_cal.xml EX-101.CAL 32098
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sgnc-20120331.xsd EX-101.SCH 11956
Mailing Address 110 FOUNDERS MILL COURT ROSWELL GA 30075
Business Address 110 FOUNDERS MILL COURT ROSWELL GA 30075 678-352-9060
SANGUINE CORP (Filer) CIK: 0000926287 (see all company filings)

IRS No.: 954347608 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-24480 | Film No.: 12842756
SIC: 2835 In Vitro & In Vivo Diagnostic Substances